Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 12 open reading frame 56 (C12orf56) is a protein-coding gene in humans with no well-characterized protein function. Transcriptomic and association studies implicate differential expression of C12orf56 in several tissues and diseases, including neurological disorders such as Dystonia 12 and Alternating Hemiplegia of Childhood. Despite its inclusion in numerous genomic datasets, the molecular and cellular functions of C12orf56 remain unknown, and it is not currently classified as a receptor, enzyme, transporter, or other characterized drug target. No drugs, mechanisms of action, or validated biomarkers are associated with C12orf56 at this time[1][2][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 12 open reading frame 56 (C12orf56).